Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSymphony Env. Regulatory News (SYM)

Share Price Information for Symphony Env. (SYM)

Share Price is delayed by 15 minutes
Get Live Data
6.75    0.00 (0.00%)
Bid:
6.00
Ask:
7.50
Spread: 1.50 (25.00%)
Market Cap: £15.95m
SYM Live PriceLast checked at - London Stock Exchange

Intraday Symphony Env. Share Chart

Trading & Operations Update

6 Aug 2018 07:00

RNS Number : 8852W
Symphony Environmental Tech. PLC
06 August 2018
 

 

6 August 2018

The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is considered to be in the public domain

 

Trading & Operations Update

("Symphony", the "Group" or the "Company")

 

Symphony Environmental Technologies Plc (AIM: SYM), a global specialist in products and technologies that "make plastic smarter", is pleased to provide a positive trading and operations update and healthy outlook.

Symphony's commercial proposition continues to respond positively to the global challenge of eliminating harmful plastic waste - placing the Group in a strong market position for the future.

Financial highlights (unaudited)

· Group revenues up 11% to £4.1 million for the six months to 30 June 2018 (H1-2017: £3.7million)

 

· Revenues from the Group's d2w oxo-biodegradable technologies were stable at £3.6 million (H1-2017: £3.6 million). However, due to US dollar depreciation in the period compared with H1-2017, d2w revenues on a constant currency basis would have been approximately 11% higher. Ramadan and Eid (17 May to 15 June) also significantly reduced June sales from Symphony's main Middle East market with orders being deferred to July

 

· Revenues from the Group's d2p anti-microbial technologies increased significantly to £0.5 million for the six months to 30 June 2018 (H1-2017: £0.0 million)

 

· Sales and marketing spend increased by approximately £0.2 million during H1-2018 in line with management expectations

 

· Healthy balance sheet with net cash of £0.6 million at 30 June 2018 (31 December 2017: £0.6 million, 30 June 2017: net debt £0.6 million)

 

· The second half of the year has started well and the Board are confident the Group will meet full year market expectations

 

Operational highlights

d2w "oxo-biodegradable" ("OXO")

· OXO technologies continue to represent the majority of the Group's revenues and are principally derived from outside Europe

· These products are mainly for single use plastics which include, but are not limited to, shopping bags, bin liners, diapers, coffee capsules, drinking straws, agricultural and food and other packaging films

· Increasing regulation in favour of OXO type additives. Eleven governments globally have now mandated that certain plastic products must contain oxo-biodegradable additives

· More robust enforcement of this legislation is generating increased d2w revenues, particularly in the Middle East and Pakistan

· Eco-label for d2w renewed by Brazillian standards authority, ABNT, following a full audit

· Pursuant to the Oxomar Project ("OXOMAR" - see notes below) which is sponsored by ANR, the French National Research Agency, French scientists have recently published a paper demonstrating enhanced bacterial colonisation of degraded oxo-biodegradable plastics

 

d2p "designed to protect"

· Symphony has continued to invest into a range of speciality products which are synergistic with its customer base so as to expand the product offering.

· Latex and nitrile household glove sales increasing significantly in Italy, and now listed in numerous large retail outlets

· Anti-microbial glove sales also increasing in the UAE and the United States

· Having launched the world's first d2p antimicrobial water pipe in Pakistan last year, repeat orders were placed in the period.

· NSF International has certified d2p antimicrobial masternatch for use in water pipes for North America having conformed with the requirements of NSF/ANSI Standard 61 - Drinking Water System Components

· Flame retardant approvals obtained in the United States (NF94 and NFPA standards), the UK (LPS 1207) and the EU (NFP 92-503)

· Range of d2p products expanded with production of hospital overalls, examination gloves and tooth brushes having commenced in the period

 

Michael Laurier, Symphony CEO said: "The momentum we announced in our Trading Update on 15 May 2018 has continued, particularly on a constant currency basis, but also and inspite of a quieter June for our d2w OXO technologies due to Ramadan and Eid affecting our Middle East markets.

"In addition, the Group's investment in and development of innovative new products in our d2p range of products is driving commercial growth. The Italian market for d2p retail gloves is progressing strongly as more stores are listing the product and our distributor is performing well.

"Our strategy to become a multi-product Group continues to progress as more of our projects reach the commercialisation phase. Symphony has a growing range of "making plastic smarter" technologies as additives for use by plastic producers and innovative finished products for end customer use.

"Whilst recent media coverage has not fairly presented the scientifically proven benefit of oxo-biodegradable technology such as d2w OXO, the recent paper by French scientists is consistent with the conclusions of the many other studies and tests performed on d2w OXO over the last 20+ years.

"Symphony's d2w OXO technology is validated in terms of degradability, biodegradability, and ecotoxicity by reference to existing European and US Standards, and also conforms with the EU Packaging Waste Directive.

 "The Board is of the view that this is a pivitol period, with growing demand for our suite of technologies. We expect to sell record volumes of both our d2w and d2p products this year and look forward to the second half of the year with optimism. We are confident the Group will meet market expectations for this financial year."

 

Enquiries

 

Symphony Environmental Technologies Plc

 

Michael Laurier, CEO

Tel: +44 (0) 20 8207 5900

Ian Bristow, CFO

 

www.symphonyenvironmental.com

 

 

Cantor Fitzgerald Europe (Nominated Adviser and Broker)

 

David Foreman/Richard Salmond (Corporate Finance)

Tel: +44 (0) 20 7894 7000

Caspar Shand Kydd (Sales)

 

 

FTI Consulting (Financial PR)

 

Daniel Hamilton

Tel: +44 (0) 7813 456720

 

NOTES TO EDITORS:

About Symphony Environmental Technologies plc

Symphony has developed and continues to develop, controlled-life plastic technology which helps tackle the problem of microplastics by turning ordinary plastic at the end of its service-life into biodegradable materials. It is then no longer a plastic and can be bioassimilated in the open environment in the same way as a leaf. The technology is branded d2w® and appears as a droplet logo on many thousands of tonnes of plastic packaging and other plastic products around the world. In some countries, most recently Saudi Arabia, oxo-biodegradable plastic is mandatory.

In addition, Symphony has developed a range of additives, concentrates and master-batches marketed under its d2p® brand, which can be incorporated in a wide variety of plastic and non-plastic products so as to give them protection against many different types of bacteria, fungi, algae, moulds, and insects, and against fire. d2p products also include odour, moisture and ethylene adsorbers as well as other types of food-preserving technologies. We have also launched d2p anti-microbial household gloves and are developing a range of other d2p finished products for retail sale.

Symphony has also developed the d2Detector®, a portable device which analyses plastics and detects counterfeit products. This is useful to government officials tasked with enforcing legislation, and Symphony's d2t tagging and tracer technology is available for further security.

Symphony has a diverse and growing customer-base and has established itself as an international business with 74 distributors around the world. Products made with Symphony's plastic technologies are now available in nearly 100 countries and in many different product applications. Symphony itself is accredited to ISO9001 and ISO14001.

Symphony is a member of The Oxo-biodegradable Plastics Association (www.biodeg.org) (OPA), the Society for the Chemical Industry (UK), and the Pacific Basin Environmental Council. Symphony is also a strategic partner of the Commonwealth business initiative, and actively participates in the Committee work of the British Standards Institute (BSI), the American Standards Organisation (ASTM), the European Standards Organisation (CEN), and the International Standards Organisation (ISO).

Further information on the Symphony Group can be found at www.symphonyenvironmental.com and twitter @SymphonyEnv See also Symphony on Instagram A Symphony App is available for downloading to smartphones.

BBC World Service film introducing d2w oxo-biodegradable (controlled-life) plastic technology

From within the UK- http://www.symphonyenvironmental.com/d2w/d2w-brochure-5/

From outside of the UK - http://www.bbc.com/storyworks/the-british-bid/symphony

About OXOMAR

The OXOMAR project commenced in 2017 and is sponsored by ANR, the French National Research Agency. For further details on OXOMAR please see the following links

http://www.agence-nationale-recherche.fr/en/anr-funded-project/?tx_lwmsuivibilan_pi2%5BCODE%5D=ANR-16-CE34-0007

http://lomic.obs-banyuls.fr/fr/axe_4_ecotoxicologie_et_ingenierie_metabolique_microbienne/oxomar.html

For details of the paper referred to above:

Dussud, C., Hudec, C., George, M., Fabre, P., Higgs, P., Bruzaud, S., Delort, A., Eyheraguibel, B., Meistertzheim, A., Jacquin, J., Cheng, J., Callac, N., Odobel, C., Rabouille, S. and Ghiglione, J. (2018). Colonization of Non-biodegradable and Biodegradable Plastics by Marine Microorganisms. Frontiers in Microbiology, 9.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTGMGGRMKKGRZZ
Date   Source Headline
29th May 201812:51 pmRNSDirector/PDMR Shareholding
21st May 20181:01 pmRNSExercise of Warrants and Director Dealing
15th May 20184:40 pmRNSSecond Price Monitoring Extn
15th May 20184:35 pmRNSPrice Monitoring Extension
15th May 201812:02 pmRNSResult of AGM
15th May 20187:01 amRNSAGM Statement
15th May 20187:00 amRNSTrading and Operations Update
3rd May 20187:00 amRNSNew Product Launches
1st May 20187:00 amRNSCollaboration Agreement and Strategic Investment
20th Apr 20187:00 amRNSSymphony Director on Sky News
19th Apr 20187:00 amRNSPosting of Accounts and Notice of AGM
18th Apr 20187:00 amRNSResults of YouGov survey
10th Apr 20187:00 amRNSOxo-biodegradable plastic legislation
9th Apr 20188:10 amRNSRemarks Delivered at 2018 ECOSOC Partnership Forum
6th Apr 20187:00 amRNSDirectorate Change
22nd Mar 201810:35 amRNSDirector Shareholding
14th Mar 20187:00 amRNSPreliminary Results
13th Mar 20183:57 pmRNSExercise of Options & Issue of New Ordinary Shares
2nd Mar 20187:00 amRNSExercise of Options
30th Jan 20187:00 amRNSIntroduction to d2w on the BBC World Service
12th Jan 201810:14 amRNSInterview on Sky News
8th Jan 20182:43 pmRNSDirector/PDMR Shareholding
4th Jan 20184:15 pmRNSExercise of Options
4th Jan 20184:09 pmRNSExercise of Options & Issue of New Ordinary
4th Jan 20187:00 amRNSTrading Update
15th Dec 20177:00 amRNSCourt Approval of Capital Reduction
30th Nov 20177:00 amRNSCapital Reduction Effective Date
8th Nov 201712:26 pmRNSResult of EGM
7th Nov 20171:57 pmRNSNotification of Major Holdings
27th Oct 20177:00 amRNSTrading Update
19th Oct 20177:00 amRNSProposed Capital Reduction & Notice of EGM
29th Sep 20177:00 amRNSHolding(s) in Company
7th Sep 20177:00 amRNSInterim Results
11th Jul 20173:49 pmRNSHolding(s) in Company
31st May 20177:00 amRNSDirector/PDMR Shareholding
22nd May 20172:34 pmRNSDirector/PDMR Shareholding
12th May 201710:54 amRNSResult of AGM
12th May 20177:00 amRNSAGM Statement
9th May 20174:34 pmRNSExercise of Options
9th May 201710:47 amRNSExercise of Options
4th May 201711:25 amRNSDirector/PDMR Shareholding
3rd May 201711:29 amRNSExercise of Options and Director Dealing
25th Apr 20173:19 pmRNSDirector/PDMR Shareholding
25th Apr 20178:54 amRNSDirector/PDMR Shareholding
20th Apr 201712:43 pmRNSDirector/PDMR Shareholding
19th Apr 201712:31 pmRNSExercise of Options
19th Apr 20177:00 amRNSSaudi Arabia Legislation Enforcement
6th Apr 20177:00 amRNSAdmission of Securities to Trading on AIM
28th Mar 20178:27 amRNSExercise of Options and Issue of Equity
27th Mar 20178:13 amRNSPosting of Annual Report & Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.